Gabelli Funds LLC 2seventy Bio, Inc. Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$8.57 - $17.0 $10,001 - $19,839	-1,167 Reduced 10.06%	10,433 $97,000
Q1 2022 May 18, 2022	BUY	$11.67 - $26.72 $135,372 - $309,952	11,600 New	11,600 $198,000
Q1 2022 May 13, 2022	SELL	$11.67 - $26.72 $140,740 - $322,243	-12,060 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.77 - $42.56 $166,066 - $513,273	12,060 New	12,060 $309,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $115M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.